Laminin antibody

Cat# MBS534539-0,25mL

Size : 0.25mL

Brand : MyBiosource

Contact local distributor :


Phone : +1 850 650 7790

Laminin (LAMC2) Antibody – Rabbit Polyclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS534539

MBS534539 is an antibody targeting LAMC2. Also known as Laminin antibody. Reactive in Boving, Human, Mouse, Pig, Rabbit, Rat. Host: Rabbit. Rabbit polyclonal Laminin antibody More details

Product Overview

Online Datasheet in PDF
Product Name
Laminin (LAMC2), Polyclonal Antibody
Full Product Name
Laminin antibody
Product Gene Name
anti-LAMC2 antibody
Product Synonym Names
Polyclonal Laminin; Anti-Laminin; Laminin B1 chain; LAMB1; Laminin alpha 1; Laminin A chain; LAMA1; Laminin alpha 1 chain; Laminin subunit beta 1
Clonality
Polyclonal
Isotype
IgG1
Host
Rabbit
Species Reactivity
Boving, Human, Mouse, Pig, Rabbit, Rat
Form/Format
PBS with 1% BSA and 0.1% NaN3.
Concentration
250ul per vial (lot specific)
Specificity
Murine laminin
Preparation and Storage
Store at 4 degree C for short term storage. Aliquot and store at -20 degree C for long term storage. Avoid repeated freeze/thaw cycles.
OMIM
150292
3D Structure
ModBase 3D Structure for Q13753
Cross-Reactivity
Bovine, Human, Mouse, Pig, Rabbit, Rat, Positive control: Skin and kidney. There was no cross-reaction with human type I, III, IV and V collagen in immunoblotting. The antibody reacted with a distinct band of apprximately 200-220kDa from 8M Urea ext.
Biohazard Information
This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
Immunogen
Laminin antibody was raised in rabbit using laminin isolated from EHS-mouse sarcoma as the immunogen.

Product Categories/Family for anti-LAMC2 antibody

Differentiation & Development
Applications Tested/Suitable for anti-LAMC2 antibody
Immunohistochemistry (IHC) Formalin/Paraffin, Western Blot (WB)
Application Notes for anti-LAMC2 antibody
Suitable for Immunoblotting, Immunohistochemistry (IHC), and for frozen tissue paraffin sections (proteolytic treatment required; enzyme: pepsin). Working dilution: 1:50-1:100.
Optimal conditions to be determined by end user.

Other Notes

Small volumes of anti-LAMC2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Additional Details

NCBI/Uniprot data below describe general gene information for LAMC2. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
NCBI Accession #
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
NCBI Official Full Name
Laminin
NCBI Official Synonym Full Names
laminin, gamma 2
NCBI Official Symbol
LAMC2
NCBI Official Synonym Symbols
B2T; CSF; EBR2; BM600; EBR2A; LAMB2T; LAMNB2
UniProt Protein Name
Laminin subunit gamma-2
UniProt Synonym Protein Names
Cell-scattering factor 140 kDa subunit; CSF 140 kDa subunit; Epiligrin subunit gamma; Kalinin subunit gamma; Kalinin/nicein/epiligrin 100 kDa subunit; Ladsin 140 kDa subunit; Laminin B2t chain; Laminin-5 subunit gamma; Large adhesive scatter factor 140 kDa subunit; Nicein subunit gamma
Protein Family
Laminin
UniProt Gene Name
LAMC2
UniProt Synonym Gene Names
LAMB2T; LAMNB2; CSF 140 kDa subunit
UniProt Entry Name
LAMC2_HUMAN
NCBI Protein Information
laminin subunit gamma-2

NCBI Summary for LAMC2

Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins, composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively), have a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the gamma chain isoform laminin, gamma 2. The gamma 2 chain, formerly thought to be a truncated version of beta chain (B2t), is highly homologous to the gamma 1 chain; however, it lacks domain VI, and domains V, IV and III are shorter. It is expressed in several fetal tissues but differently from gamma 1, and is specifically localized to epithelial cells in skin, lung and kidney. The gamma 2 chain together with alpha 3 and beta 3 chains constitute laminin 5 (earlier known as kalinin), which is an integral part of the anchoring filaments that connect epithelial cells to the underlying basement membrane. The epithelium-specific expression of the gamma 2 chain implied its role as an epithelium attachment molecule, and mutations in this gene have been associated with junctional epidermolysis bullosa, a skin disease characterized by blisters due to disruption of the epidermal-dermal junction. Two transcript variants resulting from alternative splicing of the 3' terminal exon, and encoding different isoforms of gamma 2 chain, have been described. The two variants are differentially expressed in embryonic tissues, however, the biological significance of the two forms is not known. Transcript variants utilizing alternative polyA_signal have also been noted in literature. [provided by RefSeq, Aug 2011]
Show more

UniProt Comments for LAMC2

LAMC2: Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. Ladsin exerts cell- scattering activity toward a wide variety of cells, including epithelial, endothelial, and fibroblastic cells. Defects in LAMC2 are a cause of epidermolysis bullosa junctional Herlitz type (H-JEB); also known as junctional epidermolysis bullosa Herlitz-Pearson type. JEB defines a group of blistering skin diseases characterized by tissue separation which occurs within the dermo-epidermal basement membrane. H-JEB is a severe, infantile and lethal form. Death occurs usually within the first six months of life. Occasionally, children survive to teens. H-JEB is marked by bullous lesions at birth and extensive denudation of skin and mucous membranes that may be hemorrhagic. 2 isoforms of the human protein are produced by alternative splicing.

Protein type: Secreted; Secreted, signal peptide; Extracellular matrix; Motility/polarity/chemotaxis

Chromosomal Location of Human Ortholog: 1q25-q31

Cellular Component: extracellular space; laminin-5 complex; laminin-2 complex; membrane; perinuclear region of cytoplasm; extracellular region; cell cortex

Molecular Function: heparin binding

Biological Process: extracellular matrix disassembly; epidermis development; extracellular matrix organization and biogenesis; hemidesmosome assembly; cell adhesion

Disease: Epidermolysis Bullosa, Junctional, Non-herlitz Type; Epidermolysis Bullosa, Junctional, Herlitz Type
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Products associated with anti-LAMC2 antibody

 Reference Product  PubMed Publications
 LAMB3 antibody  >57 publications with LAMC2 and LAMB3
 LAMA3 antibody  >54 publications with LAMC2 and LAMA3
 ITGB4 antibody  >12 publications with LAMC2 and ITGB4
 COL17A1 antibody  >10 publications with LAMC2 and COL17A1
 MMP2 antibody  >3 publications with LAMC2 and MMP2
 COL7A1 antibody  >3 publications with LAMC2 and COL7A1
 ITGA6 antibody  >2 publications with LAMC2 and ITGA6
 ITGA3 antibody  >1 publications with LAMC2 and ITGA3
 BMP1 antibody  >1 publications with LAMC2 and BMP1

Pathways associated with anti-LAMC2 antibody

 Products by Pathway  Pathway Diagram
 Alpha6-Beta4 Integrin Signaling Pathway antibodies  Alpha6-Beta4 Integrin Signaling Pathway Diagram
 Amoebiasis Pathway antibodies  Amoebiasis Pathway Diagram
 Amoebiasis Pathway antibodies  Amoebiasis Pathway Diagram
 Anchoring Fibril Formation Pathway antibodies  Anchoring Fibril Formation Pathway Diagram
 Assembly Of Collagen Fibrils And Other Multimeric Structures Pathway antibodies  Assembly Of Collagen Fibrils And Other Multimeric Structures Pathway Diagram
 Cell Junction Organization Pathway antibodies  Cell Junction Organization Pathway Diagram
 Cell-Cell Communication Pathway antibodies  Cell-Cell Communication Pathway Diagram
 Collagen Formation Pathway antibodies  Collagen Formation Pathway Diagram
 Degradation Of The Extracellular Matrix Pathway antibodies  Degradation Of The Extracellular Matrix Pathway Diagram
 ECM-receptor Interaction Pathway antibodies  ECM-receptor Interaction Pathway Diagram

Diseases associated with anti-LAMC2 antibody

 Disease Name  Pubmed Publications
 Carcinoma Antibodies  >115 publications with LAMC2 and Carcinoma
 Epidermolysis Bullosa, Junctional Antibodies  >60 publications with LAMC2 and Epidermolysis Bullosa, Junctional
 Congenital Abnormalities Antibodies  >59 publications with LAMC2 and Congenital Abnormalities
 Neoplasms, Experimental Antibodies  >14 publications with LAMC2 and Neoplasms, Experimental
 Lung Neoplasms Antibodies  >12 publications with LAMC2 and Lung Neoplasms
 Liver Neoplasms Antibodies  >10 publications with LAMC2 and Liver Neoplasms
 Disease Models, Animal Antibodies  >9 publications with LAMC2 and Disease Models, Animal
 Precancerous Conditions Antibodies  >8 publications with LAMC2 and Precancerous Conditions
 Liver Diseases Antibodies  >8 publications with LAMC2 and Liver Diseases
 Inflammation Antibodies  >6 publications with LAMC2 and Inflammation

Organs/Tissues associated with anti-LAMC2 antibody

 Organ/Tissue Name  Pubmed Publications
 Skin Antibodies  >73 publications with LAMC2 and Skin
 Mouth Antibodies  >32 publications with LAMC2 and Mouth
 Lung Antibodies  >17 publications with LAMC2 and Lung
 Lymph Node Antibodies  >15 publications with LAMC2 and Lymph Node
 Liver Antibodies  >12 publications with LAMC2 and Liver
 Embryonic Tissue Antibodies  >11 publications with LAMC2 and Embryonic Tissue
 Stomach Antibodies  >10 publications with LAMC2 and Stomach
 Bone Antibodies  >10 publications with LAMC2 and Bone
 Vascular Antibodies  >9 publications with LAMC2 and Vascular
 Nerve Antibodies  >8 publications with LAMC2 and Nerve